Due to the phenotype of this case, we sought to identify additional cases of paternal IGF2 inactivation through either structural chromosomal abnormalities, IGF2 gene mutations or IGF2/H19 methylation abberrations, by screening women with similar characteristics of intrauterine growth restriction, short stature, insulin resistance and precocious pubarche. The gene discussed is H19; the disease is fetal growth restriction.